-
The View From a CAR T-Cell Clinical Trial
After exhausting her treatment options, Ellen Reich got CAR T-cell treatment for multiple myeloma through a clinical trial.
by Pamela Rafalow Grossman
-
Diet and Cancer: Getting the Research Onto Your Plate
New studies each year purport to show associations between certain foods and cancer. Experts say to focus on the big picture.
by Anne Danahy
-
How Common Are Treatment Breakthroughs?
A new study adds nuance to the ‘golden age’ of cancer drug approvals.
by Jon Kelvey
-
New Guidelines Recommend Exercise for Most Cancer Patients
People in treatment for early-stage cancer should try to get exercise, according to new recommendations.
by Sandra Gordon
-
E-Cigarettes Don’t Live Up to Promises
New studies find that electronic cigarettes trail other methods in helping people quit smoking, but they are growing in popularity among teens.
by Teresa Bergen
-
A Look at Disparities Across Cancer Care
A new AACR report tracks progress in addressing cancer health disparities and identifies work that still needs to be done.
by Eric Fitzsimmons
-
Credit Agencies to Remove Some Medical Debt From Reports
Changes to what medical debt is included in credit reports could give patients more time to resolve outstanding bills.
by Karon Warren
-
The Mental Toll of a Cancer Diagnosis
New studies shine a light on the effects of a cancer diagnosis on mental health and suicide risk.
by Pamela Rafalow Grossman
-
Access to Health Insurance Key to Disparities in Cancer Outcomes
As outcomes improved for cancer patients in states that expanded Medicaid, disparities in survival disappeared.
by Jon Kelvey
-
T Cells Key to COVID-19 Vaccination Efforts
Experts discuss shortcomings of current COVID-19 vaccines in people with cancer while highlighting possibilities of T-cell activation.
by Thomas Celona
Cancer Talk
Most Cancer Survivors Don’t Meet Healthy Diet Goals
Despite research linking fruits and vegetables to cancer survival, many people do not change their eating habits after diagnosis.
by Darlene Dobkowski
Many People Don’t Get Colonoscopy After Receiving Abnormal Blood TestsAbout half of people who receive abnormal results from colorectal cancer screening tests don’t follow up with a colonoscopy.
by Laura Gesualdi Gilmore
Can Steroids Impair Immunotherapy for Cancer?A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon